The procedure was performed via femoral access by a team consisting of: Prof. Zenon Huczek (operator), Dr. Adam Rdzanek (operator), Dr. Bartosz Rymuza (operator), Dr. Nicolo Piazza (proctor, McGill University, Montreal), Dr. Piotr Scisło (echonavigator), Dr. Jean Buithieu (procotor, McGill University, Montreal), Dr. Tadeusz Bering (cardiac anesthesiologist) and nurses - Grażyna Drozdowska and Renata Makowska.
The implantation was performed in a 69-year-old patient with severe functional mitral regurgitation and high risk of classical cardiac replacement (history of myocardial infarction, coronary artery bypass grafting, and stroke). During 30-day follow-up, good bioprosthesis function and absence of cardiovascular complications of the procedure were confirmed.
Transcatheter mitral valve implantation (TMVI) with bioprosthesis, like aortic bioprosthesis implantation (TAVI) 20 years ago, is undoubtedly a milestone in the treatment of patients with valvular heart defects. By launching the percutaneous mitral valve prosthesis implantation program, the 1st Department of Cardiology joins the few centers in the world that perform transcatheter implantation and repair of all heart valves: mitral TMVI/TMVR, tricuspid (TTVR), aortic (TAVI) and pulmonary artery valve (PTVI).
Photograph: dr. Piotr Ścisło